Ozempic vs Rybelsus: Which Medication Is Right For You?

Medical treatment from licensed providers is provided by the “LifeMD Affiliated P.C.s,” an affiliated network of medical Professional Corporations and Associations. Rybelsus, being an oral tablet, offers a more convenient option for patients who may be averse to injections. Dr. Jennifer Nadel is a board certified emergency medicine physician and received her medical degree from the George Washington University School of Medicine. They will review your medical history and help you decide which medication may be best for you or if there is another more suitable option.

As an oral version of Ozempic, Rybelsus may be in higher demand for those looking for a non-injection option for managing blood sugar levels. Rybelsus and Ozempic are brand-name prescription medications manufactured by Novo Nordisk. In most cases, Rybelsus and Ozempic are covered by Medicare and private insurance plans when prescribed for Type 2 diabetes. They’re generally not covered for off-label purposes like weight management.

Rybelsus vs. Ozempic: Uses & Ingredients

They belong to a class of drugs called glucagon-like peptide-1 (GLP-1) agonists. A class of drugs is a group of medications that act in a similar way. Rybelsus (semaglutide) and Ozempic (semaglutide) are brand-name drugs. They’re both prescribed to help manage blood sugar levels in adults with type 2 diabetes. Continue reading to learn about the drugs’ effectiveness, cost, and more. The Food and Drug Administration (FDA) has approved both Rybelsus and Ozempic for controlling blood sugar levels in adults with type 2 diabetes, along with diet and exercise.

Ozempic is also used to reduce the risk of serious heart problems in people who have type 2 diabetes and heart disease. It reduces the risk of having a heart attack, having a stroke, and dying from heart disease. Rybelsusis a 3mg white to light yellow oval-shaped tablet taken once daily for the first 30 days.

Compare Drugs

The results showed that the oral doses of 2.5, 5, 10, and 20 mg semaglutide lowered the mean AIC by 0.7%, 1.2%, 1.5%, and 1.7%, respectively, compared to a 1.9% decrease by subcutaneous semaglutide. Rybelsus and Ozempic are prescription medications containing the active drug semaglutide. The Food and Drug Administration (FDA) approved these medications for blood sugar rybelsus to buy control in people living with type 2 diabetes. With so many on the market, knowing which is right for you can take a lot of work. With hefty price tags and possible side effects, it can feel like a high-stakes decision. Here, we break down the difference between two commonly-prescribed medications used to treat type 2 diabetes and obesity — Rybelsus® and Ozempic®.

That step up came with the FDA approval of a new GLP-1 receptor agonist called semaglutide, best known as a weekly injection to treat type 2 diabetes that is sold under the brand name Ozempic. The drug was first approved for that purpose in 2017 and was then approved as a type 2 diabetes pill called Rybelsus and, most recently, as an injection to treat obesity called Wegovy. Rybelsus and Ozempic are both semaglutide, a GLP-1 receptor agonist drug. Rybelsus is an oral, once-daily medication and Ozempic is a weekly injectable medication. GLP-1 receptor agonists slow the rate of digestion, which can make you feel fuller longer after you eat.